CN113880911A - Synthesis method of glycyl-L-tyrosine - Google Patents
Synthesis method of glycyl-L-tyrosine Download PDFInfo
- Publication number
- CN113880911A CN113880911A CN202111078247.1A CN202111078247A CN113880911A CN 113880911 A CN113880911 A CN 113880911A CN 202111078247 A CN202111078247 A CN 202111078247A CN 113880911 A CN113880911 A CN 113880911A
- Authority
- CN
- China
- Prior art keywords
- compound
- solvent
- tyrosine
- glycyl
- dioxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 title claims abstract description 27
- 108010087823 glycyltyrosine Proteins 0.000 title claims abstract description 27
- 238000001308 synthesis method Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 26
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004471 Glycine Substances 0.000 claims abstract description 12
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 11
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 38
- 239000002904 solvent Substances 0.000 claims description 33
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- 229960004441 tyrosine Drugs 0.000 claims description 16
- 229960001701 chloroform Drugs 0.000 claims description 14
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 14
- 239000002585 base Substances 0.000 claims description 13
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 12
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 11
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- -1 p-toluenesulfonyl Chemical group 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical group FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical group CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 4
- LQVMZVKOVPITOO-UHFFFAOYSA-N 9h-fluoren-1-ylmethyl carbonochloridate Chemical group C1C2=CC=CC=C2C2=C1C(COC(=O)Cl)=CC=C2 LQVMZVKOVPITOO-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Chemical group O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 4
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 3
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Chemical group C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical group ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims description 3
- 229940073608 benzyl chloride Drugs 0.000 claims description 3
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical group CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 claims description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical group CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 3
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical group C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 2
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical group ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 claims description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical group COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 3
- 125000002252 acyl group Chemical group 0.000 abstract description 2
- 238000005660 chlorination reaction Methods 0.000 abstract description 2
- 238000010511 deprotection reaction Methods 0.000 abstract description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 2
- 238000007670 refining Methods 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- ZAKRZZDABWCUGW-UHFFFAOYSA-N 2-aminoacetyl chloride;hydrochloride Chemical compound Cl.NCC(Cl)=O ZAKRZZDABWCUGW-UHFFFAOYSA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 235000012501 ammonium carbonate Nutrition 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SBBWEQLNKVHYCX-JTQLQIEISA-N ethyl L-tyrosinate Chemical compound CCOC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-JTQLQIEISA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a method for synthesizing glycyl-L-tyrosine, belonging to the technical field of organic synthesis. The method comprises the steps of taking glycine as an initial raw material, and finally obtaining the glycyl-L-tyrosine with high purity through amino protection, acyl chlorination, peptide grafting, deprotection and refining. The method has the advantages of cheap and easily obtained starting raw materials, mild conditions, high kettle efficiency, simple and controllable impurities and the like, and provides a feasible scheme for the process research of glycyl-L-tyrosine.
Description
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly discloses a synthetic method of glycyl-L-tyrosine.
Background
As one of the main components of parenteral nutrition preparation compound amino acid (15) dipeptide (2) injection, glycyl-L-tyrosine belongs to artificially synthesized dipeptide amino acid, and mainly provides L-tyrosine for patients to ensure hyperthyroidism so as to promote protein synthesis. Therefore, glycyl-L-tyrosine has wide development space in the medical field.
The currently disclosed synthetic methods of glycyl-L-tyrosine mainly comprise the following steps:
the method comprises the following steps: U.S. Pat. No. 4, 6197998, 1 reports a synthetic scheme using chloroacetyl chloride and L-tyrosine as starting materials, which is acylated, aminolyzed, and purified to obtain glycyl-L-tyrosine. Although the steps are short, the chloroacetyl chloride as the starting material is high in price, a large amount of ammonia water and ammonium carbonate are needed, the kettle efficiency is very low, the reaction time is too long, and the industrial three wastes are high.
The second method comprises the following steps: european patent EP311057 (1998) reports a synthetic scheme in which N-succinimide and benzyloxycarbonylglycine are first prepared into an active ester, then condensed with tyrosine ethyl ester to form a peptide by a condensing agent, and then hydrolyzed to obtain glycyl tyrosine.
The third scheme is as follows: chinese patent CN103172695B reports a synthesis scheme using glycine and L-tyrosine as starting materials, in which glycine directly reacts with thionyl chloride to prepare glycine chloride hydrochloride, and then the glycine chloride hydrochloride is condensed with tyrosine under an alkaline condition to generate glycyl tyrosine, in the scheme, the amino group of glycine is not protected and directly prepares acyl chloride, and the reaction product is very complex, so that the yield of the target product is very low and is difficult to purify, and industrial production cannot be realized.
Therefore, the development of an industrial method for synthesizing glycyl-L-tyrosine, which has the advantages of low cost, high kettle efficiency, small wastewater amount and controllable impurities, is a problem to be solved urgently at present.
Disclosure of Invention
The invention provides a method for synthesizing glycyl-L-tyrosine, which has the following reaction equation:
wherein R is selected from benzyl, benzyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, fluorenyl methoxycarbonyl, phthaloyl, p-toluenesulfonyl or trifluoroacetyl, etc.
The invention provides a method for synthesizing glycyl-L-tyrosine, which comprises the following steps:
(1) in a solvent A, glycine, a base A and a compound R react at 0-120 ℃ to obtain a compound I, wherein the molar ratio of the glycine to the base A to the compound R is 1: 0.5-3.0: 1.0-2.5. Wherein, the compound R is selected from benzyl chloride, benzyl chloroformate, methyl chloroformate, ethyl chloroformate, fluorenyl methoxy carbonyl chloride, phthalic anhydride, p-toluenesulfonyl chloride or trifluoroacetic anhydride, etc.; preferably fluorenyl methoxycarbonyl chloride, phthalic anhydride or trifluoroacetic anhydride.
(2) In a solvent B, reacting a compound I, DMF and thionyl chloride at 25-80 ℃ to obtain a compound II, wherein the molar ratio of the compound I to the DMF to the thionyl chloride is 1: 0.01-0.5: 1-3.
(3) Dissolving L-tyrosine and alkali B in a solvent C to obtain a solvent C system, dissolving a compound II in a solvent D, dropwise adding the solvent C system, and reacting at 0-30 ℃ to obtain a compound III, wherein the molar ratio of the compound II to the alkali B to the L-tyrosine is 1: 0.5-3: 0.8-2.5.
(4) When R is benzyl or benzyloxycarbonyl, reacting a compound III with hydrogen in a solvent E under the action of a catalyst at 25-60 ℃ to obtain a compound IV, wherein the mass ratio of the compound III to the catalyst is 1: 0.1-0.5, the pressure of hydrogen is 0.01-1 Mpa;
when R is methoxycarbonyl or ethoxycarbonyl, reacting a compound III with strong acid or strong base in a solvent F at 0-50 ℃ to obtain a compound IV, wherein the molar ratio of the compound III to the strong acid or strong base is 1: 1-4;
when R is fluorenyl methoxycarbonyl, phthaloyl, p-toluenesulfonyl or trifluoroacetyl, reacting a compound III with organic amine or inorganic amine at 25-75 ℃ in a solvent G to obtain a compound IV, wherein the molar ratio of the compound III to the organic amine or the inorganic amine is 1: 1-3.
Wherein, the solvent A is selected from toluene, dichloromethane, trichloromethane, methanol, ethanol, tetrahydrofuran or dioxane, etc., the alkali A is selected from triethylamine, pyridine, DBU, sodium carbonate, potassium carbonate or sodium hydroxide, etc., and dioxane, dichloromethane or trichloromethane are preferred.
The solvent B is selected from toluene, dichloromethane, trichloromethane, tetrahydrofuran, acetonitrile, dioxane or acetone, and is preferably toluene or trichloromethane.
Wherein, the solvent C is selected from water, toluene, dichloromethane, trichloromethane, tetrahydrofuran, acetonitrile, dioxane or acetone, etc., and is preferably water or acetone; the solvent D is selected from toluene, dichloromethane, trichloromethane, tetrahydrofuran, acetonitrile, dioxane or acetone, and the like, and is preferably trichloromethane or acetone; the base B is selected from triethylamine, pyridine, DBU, sodium carbonate, potassium carbonate or sodium hydroxide, etc., preferably sodium hydroxide (corresponding to water) or triethylamine (corresponding to organic solvent).
Wherein, the solvent E is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, etc., and the catalyst is selected from palladium carbon or Raney nickel, etc.
Wherein, the solvent F is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, etc., and the strong acid or strong base is selected from sodium hydroxide, potassium hydroxide, hydrochloric acid, sulfuric acid or hydrobromic acid, etc.
Wherein, the solvent G is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, etc., preferably water, methanol or tetrahydrofuran; the organic amine or inorganic amine is selected from ammonia, hydrazine hydrate, piperidine, ethanolamine, cyclohexylamine or DBU, etc., preferably ammonia, hydrazine hydrate or piperidine.
The method comprises the steps of taking glycine as an initial raw material, and finally obtaining the glycyl-L-tyrosine with high purity through amino protection, acyl chlorination, peptide grafting, deprotection and refining. The method has the advantages of cheap and easily obtained starting raw materials, mild conditions, high kettle efficiency, simple and controllable impurities and the like, and provides a feasible scheme for the process research of glycyl-L-tyrosine. Specifically, the first scheme is a route which can be industrially produced at present, but in the ammonolysis process, 10-20 times of the volume of ammonia water is usually required to be added, and the volume of materials and the volume of ammonium carbonate solution are added, so that the kettle efficiency is relatively low. The solvent volume of the method is within 5 times of that of the materials, and the kettle efficiency is high. In addition, the method is a continuous-feeding reaction, does not need purification in the middle, reduces operation, basically realizes a one-pot method for reaction, and is suitable for industrial production. Meanwhile, the method can purify the product only by adopting a recrystallization method, the concentration of the obtained product is more than 99 percent, the L-tyrosine is less than or equal to 0.3 percent, and other impurities are less than or equal to 0.1 percent, which accords with the regulations of United states pharmacopoeia.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, embodiments of the present invention are described in further detail below.
The synthetic route of the glycyl-L-tyrosine provided by the invention is as follows:
the above synthetic route is illustrated by R-group as fluorenyl-methoxycarbonyl, benzyl and ethoxycarbonyl. The R group may be any other group selected from those defined above. One skilled in the art can make adjustments to one or more steps without departing from the spirit of the present invention, and such changes are within the scope of the present application.
Synthesis of Compound I
1.1 adding 260ml dioxane, glycine (86.33 g, 1.15 mol), triethylamine (151.79 g, 1.50 mol) into a 1L three-necked bottle, stirring uniformly, dropwise adding fluorenyl methoxy carbonyl chloride (310.44 g, 1.20 mol) at the temperature of 15-35 ℃, reacting at normal temperature for 5-6h after dropwise adding, after the reaction, concentrating under reduced pressure below 50 ℃ to dryness, and directly carrying out the next reaction, wherein the molar yield is 100%.
1.2 adding 300ml of dichloromethane, glycine (86.33 g, 1.15 mol) and pyridine (118.52 g, 1.50 mol) into a 1L three-necked bottle, stirring uniformly, dropwise adding benzyl chloride (151.90 g, 1.20 mol) at the controlled temperature of 15-35 ℃, reacting at normal temperature for 5-6h after dropwise adding, concentrating under reduced pressure below 50 ℃ until the mixture is dried after the reaction is finished, and directly carrying out the next reaction, wherein the molar yield is 100%.
1.3 adding 300ml of trichloromethane, glycine (86.33 g, 1.15 mol), triethylamine (118.52 g, 1.50 mol), ethyl chloroformate (130.22 g, 1.2 mol) into a 1L three-necked bottle, keeping the temperature for 5-6h, after the reaction is finished, concentrating under reduced pressure below 50 ℃ to dryness, and directly carrying out the next reaction, wherein the molar yield is 100%.
Synthesis of (di) Compound II
2.1 putting 300ml of trichloromethane, a compound I and DMF (7.3 g, 0.1 mol) into a 1L reaction bottle, stirring and mixing uniformly, dropwise adding thionyl chloride (154.66 g, 1.3 mol) at the temperature of below 40 ℃, heating to 55-65 ℃, preserving heat for reaction for 3-4h, after the reaction is finished, concentrating under reduced pressure at the temperature of below 65 ℃ until the reaction is dried, and directly carrying out the next reaction, wherein the molar yield is 100%.
2.2 put 400ml toluene, compound I, DMF (10.95 g, 0.15 mol) into a 1L reaction bottle, stir and mix evenly, control to drip thionyl chloride (178.45 g, 1.5 mol) below 40 ℃, heat up to 55-65 ℃ after finishing dripping, keep warm and react for 3-4h, after finishing the reaction, concentrate under reduced pressure below 65 ℃ to dry, directly carry on the next reaction, the molar yield is counted as 100%.
Synthesis of (III) Compound
3.1 putting 550ml of water and L-tyrosine (181.19 g, 1.00 mol) into a 2L reaction bottle, stirring and dispersing uniformly, controlling the temperature to be 5-15 ℃, adding sodium hydroxide (60 g, 1.50 mol), keeping the temperature and stirring for 30min after the addition, dissolving a compound II in 300ml of trichloromethane, controlling the temperature to be 0-25 ℃, dropwise adding the compound II into an L-tyrosine system, completing the dropwise addition, reacting at room temperature for 3-5h, separating out a water phase after the reaction is completed, adjusting the pH =4-6, and concentrating under reduced pressure below 60 ℃ until the mixture is dried to obtain a compound III, directly carrying out the next reaction, wherein the molar yield is 100%.
3.2 putting 300ml of acetone and L-tyrosine (181.19 g, 1.00 mol) into a 2L reaction bottle, stirring and dispersing uniformly, controlling the temperature to be 5-15 ℃, adding triethylamine (202.38 g, 2.00 mol), keeping the temperature and stirring for 30min after the addition is finished, dissolving a compound II into 250ml of acetone, controlling the temperature to be 0-25 ℃, dropwise adding the compound II into an L-tyrosine system, completing the dropwise addition, reacting at room temperature for 3-5h, adjusting the pH =4-6 after the reaction is finished, and concentrating under reduced pressure below 50 ℃ until the compound II is dried to obtain a compound III, wherein the molar yield is 100%.
Synthesis of (tetra) Compound IV
4.1 when R is fluorenyl methoxycarbonyl, adding 650ml of tetrahydrofuran, the compound III and piperidine (127.54 g, 1.5 mol) into a 2L reaction bottle, stirring at normal temperature for 5-6h, after the reaction is finished, concentrating under reduced pressure below 50 ℃ until the mixture is dried, adding 476ml of water and 1000ml of ethanol for recrystallization to obtain the compound IV, wherein the total molar yield is 75%, the liquid phase purity of the product is 99.3%, L-tyrosine is less than or equal to 0.3%, and other single impurities are less than or equal to 0.1%.
4.2 when R is benzyl, adding 500g of water and 500g of methanol, a compound III and 25g of 5% palladium carbon into a high-pressure reaction kettle, uniformly stirring, introducing hydrogen to 0.5-0.8Mpa, heating to 50-60 ℃, reacting for 5-6 hours, filtering, concentrating under reduced pressure below 60 ℃ until the reaction is finished, adding 480ml of water and 1000ml of isopropanol, and recrystallizing to obtain a compound IV, wherein the total molar yield is 72%, the liquid phase purity of the product is 99.2%, the L-tyrosine content is less than or equal to 0.3%, and the other single impurities are less than or equal to 0.1%.
4.3 when R is o-ethoxycarbonyl, 600ml of dioxane, a compound III and 365g of 30% hydrochloric acid (3.00 mol) are added into a 2L reaction bottle, the temperature is gradually increased to 40-50 ℃, the reaction is carried out for 4-5 hours, after the reaction is finished, the temperature is reduced to normal temperature, the filtration is carried out, the filtrate is concentrated under reduced pressure below 60 ℃ until the filtrate is dried, 476ml of water and 1000ml of ethanol are added for recrystallization, and the compound IV is obtained, the total molar yield is 60%, the liquid phase purity of the product is 99.5%, L-tyrosine is less than or equal to 0.3%, and other single impurities are less than or equal to 0.1%.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (9)
2. A method of synthesizing glycyl-L-tyrosine according to claim 1, wherein R is selected from fluorenyl methoxy carbonyl, benzyl or ethoxy carbonyl.
3. The method of synthesizing glycyl-L-tyrosine according to claim 1, which comprises:
(1) in a solvent A, glycine, a base A and a compound R react at 0-120 ℃ to obtain a compound I, wherein the molar ratio of the glycine to the base A to the compound R is 1: 0.5-3.0: 1.0-2.5, wherein the compound R is selected from benzyl chloride, benzyl chloroformate, methyl chloroformate, ethyl chloroformate, fluorenyl methoxy carbonyl chloride, phthalic anhydride, p-toluenesulfonyl chloride or trifluoroacetic anhydride;
(2) in a solvent B, reacting a compound I, DMF and thionyl chloride at 25-80 ℃ to obtain a compound II, wherein the molar ratio of the compound I to the DMF to the thionyl chloride is 1: 0.01-0.5: 1-3;
(3) dissolving L-tyrosine and alkali B in a solvent C to obtain a solvent C system, dissolving a compound II in a solvent D, dropwise adding the solvent C system, and reacting at 0-30 ℃ to obtain a compound III, wherein the molar ratio of the compound II to the alkali B to the L-tyrosine is 1: 0.5-3: 0.8-2.5;
(4) when R is benzyl or benzyloxycarbonyl, reacting a compound III with hydrogen in a solvent E under the action of a catalyst at 25-60 ℃ to obtain a compound IV, wherein the mass ratio of the compound III to the catalyst is 1: 0.1-0.5, and the pressure of the hydrogen is 0.01-1 Mpa;
when R is methoxycarbonyl or ethoxycarbonyl, reacting a compound III with strong acid or strong base in a solvent F at 0-50 ℃ to obtain a compound IV, wherein the molar ratio of the compound III to the strong acid or strong base is 1: 1-4;
when R is fluorenyl methoxycarbonyl, phthaloyl, p-toluenesulfonyl or trifluoroacetyl, reacting a compound III with organic amine or inorganic amine at 25-75 ℃ in a solvent G to obtain a compound IV, wherein the molar ratio of the compound III to the organic amine or the inorganic amine is 1: 1-3.
4. A process for the synthesis of glycyl-L-tyrosine according to claim 3, characterized in that the solvent a is selected from toluene, dichloromethane, chloroform, methanol, ethanol, tetrahydrofuran or dioxane, and the base a is selected from triethylamine, pyridine, DBU, sodium carbonate, potassium carbonate or sodium hydroxide.
5. A process for the synthesis of glycyl-L-tyrosine according to claim 3, characterized in that the solvent B is selected from toluene, dichloromethane, chloroform, tetrahydrofuran, acetonitrile, dioxane or acetone.
6. The method for synthesizing glycyl-L-tyrosine according to claim 3, wherein the solvent C is selected from water, toluene, dichloromethane, trichloromethane, tetrahydrofuran, acetonitrile, dioxane or acetone, the solvent D is selected from toluene, dichloromethane, trichloromethane, tetrahydrofuran, acetonitrile, dioxane or acetone, and the base B is selected from triethylamine, pyridine, DBU, sodium carbonate, potassium carbonate or sodium hydroxide.
7. The method for synthesizing glycyl-L-tyrosine as claimed in claim 3, characterized in that the solvent E is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, and the catalyst is selected from palladium carbon or Raney nickel.
8. A process for the synthesis of glycyl-L-tyrosine according to claim 3, characterized in that the solvent F is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, and the strong acid or base is selected from sodium hydroxide, potassium hydroxide, hydrochloric acid, sulfuric acid or hydrobromic acid.
9. A process for the synthesis of glycyl-L-tyrosine according to claim 3, characterized in that the solvent G is selected from water, methanol, ethanol, acetone, tetrahydrofuran or dioxane, and the organic or inorganic amine is selected from ammonia, hydrazine hydrate, piperidine, ethanolamine, cyclohexylamine or DBU.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111078247.1A CN113880911B (en) | 2021-09-15 | 2021-09-15 | Synthesis method of glycyl-L-tyrosine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111078247.1A CN113880911B (en) | 2021-09-15 | 2021-09-15 | Synthesis method of glycyl-L-tyrosine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113880911A true CN113880911A (en) | 2022-01-04 |
CN113880911B CN113880911B (en) | 2023-11-14 |
Family
ID=79009175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111078247.1A Active CN113880911B (en) | 2021-09-15 | 2021-09-15 | Synthesis method of glycyl-L-tyrosine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113880911B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2268586A1 (en) * | 1998-04-14 | 1999-10-14 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing n-glycyltyrosine and its crystal structure |
CN101429227A (en) * | 2008-12-05 | 2009-05-13 | 北京博时安泰科技发展有限公司 | Refining method for Glycyl-L-tyrosine |
CN102718833A (en) * | 2012-05-16 | 2012-10-10 | 江苏诚信制药有限公司 | Preparation method of glycyl-tyrosine |
CN102993270A (en) * | 2011-09-15 | 2013-03-27 | 山东齐都药业有限公司 | Preparation process of glycyl-L-tyrosine |
CN103172695A (en) * | 2011-12-26 | 2013-06-26 | 四川科伦药物研究有限公司 | Preparation method of glycyl-tyrosine |
CN112552373A (en) * | 2020-12-08 | 2021-03-26 | 河北一品制药股份有限公司 | Industrial preparation method of glycyl-L-tyrosine |
-
2021
- 2021-09-15 CN CN202111078247.1A patent/CN113880911B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2268586A1 (en) * | 1998-04-14 | 1999-10-14 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing n-glycyltyrosine and its crystal structure |
CN101429227A (en) * | 2008-12-05 | 2009-05-13 | 北京博时安泰科技发展有限公司 | Refining method for Glycyl-L-tyrosine |
CN102993270A (en) * | 2011-09-15 | 2013-03-27 | 山东齐都药业有限公司 | Preparation process of glycyl-L-tyrosine |
CN103172695A (en) * | 2011-12-26 | 2013-06-26 | 四川科伦药物研究有限公司 | Preparation method of glycyl-tyrosine |
CN102718833A (en) * | 2012-05-16 | 2012-10-10 | 江苏诚信制药有限公司 | Preparation method of glycyl-tyrosine |
CN112552373A (en) * | 2020-12-08 | 2021-03-26 | 河北一品制药股份有限公司 | Industrial preparation method of glycyl-L-tyrosine |
Non-Patent Citations (2)
Title |
---|
KRITTIKA RALHAN等: "Piperazine and DBU: a safer alternative for rapid and efficient Fmoc deprotection in solid phase peptide synthesis", 《RSC ADV.》, pages 104417 - 104425 * |
陈环宇: "甘氨酰-L-谷氨酰胺与甘氨酰-L-酪氨酸的合成工艺研究", 《中国优秀硕士学位论文全文数据库(电子期刊)工程科技I辑》, pages 429 - 434 * |
Also Published As
Publication number | Publication date |
---|---|
CN113880911B (en) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110740994A (en) | Peptide Nucleic Acid (PNA) monomers with orthogonally protected ester moieties | |
CN110950926B (en) | Liquid phase synthesis method of snake venom-like tripeptide | |
WO2019018422A1 (en) | Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto | |
ES2259071T3 (en) | NEW ACID DERIVATIVES SYNTHESIS PROCEDURE (2S, 3AS, 7AS) -1- (S) -ALANIL-OCTAHIDRO-1H-INDOL-2-CARBOXILICO AND ITS APPLICATION TO PERINDOPRILE SYNTHESIS. | |
CN108003105B (en) | Method for synthesizing micromolecular amino acid derivative ectoin | |
CN113880911A (en) | Synthesis method of glycyl-L-tyrosine | |
CN102993271A (en) | Preparation method of glycyl-L-glutamine | |
JPH04234374A (en) | Production of diketopiperazine derivative | |
NZ544003A (en) | Novel method of synthesising perindopril and pharmaceutically-acceptable salts thereof | |
NZ521846A (en) | Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril | |
CN109369779A (en) | A kind of synthetic method of Taltirelin | |
CN113461774B (en) | Preparation method of palmitoyl tripeptide-1 | |
EP1140795A1 (en) | N-3, 3-dimethylbutyl-l-aspartic acid and esters thereof, the process of preparing the same, and the process for preparing n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine-1-methylester therefrom | |
CN112552373B (en) | Industrial preparation method of glycyl-L-tyrosine | |
CN108948157B (en) | Method for preparing telavancin | |
CN1298737C (en) | Synthesis method of dipeptide containing L-glutamine | |
CN112480208B (en) | Industrial preparation method of glycyl-L-glutamine | |
WO2012108408A1 (en) | Method for producing dipeptide and tripeptide | |
CN110627874B (en) | Preparation method of pasireotide | |
CN114105848B (en) | Preparation method of cis-D-hydroxyproline derivative | |
CN117683078A (en) | Preparation method of glycyl-L-glutamine | |
CN117964505A (en) | Synthesis method of N, N-bis (carboxymethyl) -L-lysine | |
CN117209546A (en) | Preparation method of 1-amino-1-deoxy-D-glucose | |
CN116724022A (en) | Method for producing peptide, reagent for protecting group formation, and condensed polycyclic compound | |
CN112624976A (en) | Whale carnosine intermediate, preparation method of whale carnosine and whale carnosine intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |